Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies
05 déc. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most...
alwaysAI Announces Strategic Partnership With Dr. Gabriel A. Silva, Professor of Neuroscience and Bioengineering at the University of California San Diego
27 nov. 2023 13h12 HE
|
alwaysAI
alwaysAI Announces Strategic Partnership With Dr. Gabriel A. Silva, Professor of Neuroscience and Bioengineering at the University of California San Diego
Neuroscience Market to Hit USD 65.8 Billion by 2030 Owing to Increasing Prevalence of Neurological Disorders and Collaborative Research Initiatives | Research by SNS Insider
20 nov. 2023 09h00 HE
|
SNS Insider pvt ltd
Pune, Nov. 20, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that the size of Neuroscience Market was projected to be USD 42.6 billion in 2022, with an anticipated growth to USD 65.8...
Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo
30 oct. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation
05 oct. 2023 09h00 HE
|
Precision Neuroscience
NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced it has acquired a microelectromechanical systems...
Sandoz receives FDA approval for Tyruko® (natalizumab-sztn), first and only FDA-approved biosimilar for relapsing forms of multiple sclerosis
25 août 2023 01h15 HE
|
Novartis Pharma AG
Biosimilar Tyruko® approved for all indications of reference medicine, with same dosing and administration schedule Sandoz continues to expand access to much-needed medications for patients...
NysnoBio Awarded Michael J. Fox Foundation Grant to Advance Parkin Gene Therapy
17 juil. 2023 16h05 HE
|
NysnoBio LLC
- The funding will support NB001 Parkin gene replacement therapy IND-enabling studies- Initial indication in a substantial, genetically defined Parkinson’s population: Parkin-PD- Parkin-PD mutations...
Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
22 juin 2023 03h00 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Basel, Switzerland, June 22, 2023 --In recognition of their pioneering work on restoring vision to blind patients using optogenetic therapy, Botond Roska and José-Alain Sahel were today awarded the...
Arvinas to Participate in Upcoming Investor Conferences
05 juin 2023 07h00 HE
|
Arvinas Inc.
NEW HAVEN, Conn., June 05, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
01 juin 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
Reaffirms Full Year 2023 Total Revenue Guidance of Between $375 Million and $385 Million Forecasts FIRDAPSE® 2023 Net Product Revenue Guidance of Between $245 Million and $255 Million, an...